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ABSTRACT
Risk-adjustment schemes are used to monitor hospital
performance, on the assumption that excess mortality
not explained by case mix is largely attributable to
suboptimal care. We have developed a model to
estimate the proportion of the variation in standardised
mortality ratios (SMRs) that can be accounted for by
variation in preventable mortality. The model was
populated with values from the literature to estimate a
predictive value of the SMR in this context—
speciﬁcally the proportion of those hospitals with
SMRs among the highest 2.5% that fall among the
worst 2.5% for preventable mortality. The extent to
which SMRs reﬂect preventable mortality rates is highly
sensitive to the proportion of deaths that are
preventable. If 6% of hospital deaths are preventable
(as suggested by the literature), the predictive value of
the SMR can be no greater than 9%. This value could
rise to 30%, if 15% of deaths are preventable. The
model offers a ‘reality check’ for case mix adjustment
schemes designed to isolate the preventable
component of any outcome rate.
INTRODUCTION
Hospital mortality rates are widely used as a
measure of quality in developed countries.
The Health Care Financing Administration
(HCFA) released risk-adjusted mortality data,
in the form of standardised mortality ratios
(SMRs), on all Medicare patients admitted to
hospitals in the USA in 1986.1 After years of
criticism,2–7 and attempts to improve the esti-
mates,8–11 HCFA abandoned the effort and
for a while hospital mortality data fell into
disuse as a way to assess quality of care,
outside of a single high-volume surgical pro-
cedure—coronary bypass surgery. However,
there has been a renewal of interest and a dra-
matic increase in the number of North
American hospitals publishing mortality
data.12–16 In England, adjusted mortality statis-
tics for NHS hospitals have been published
since 2001 by the Dr Foster organisation,16 17
and the Department of Health has recently
sponsored a similar approach—the Summary
Hospital Mortality Index (SHMI).18 19
However, there is little new evidence to
support such metrics as indicators of care
quality, and further evidence questioning
their validity.20 21 A recent paper concluded
that an observed lack of agreement between
different methods for calculating hospital-
wide mortality rates may result from ‘funda-
mental ﬂaws in the hypothesised association
between hospital-wide mortality and quality of
care’.22 Such a fundamental ﬂaw would arise
if the signal (preventable deaths) was small in
relation to the noise (inevitable deaths). To
further explore this possibility, we model the
correlation between overall risk-adjusted mor-
tality and mortality due to poor care.
Since a review of the relationship between
mortality and quality of care found no empir-
ical studies that directly report the relation-
ship between SMRs and preventable
mortality,21 we develop the argument from a
number of plausible scenarios using a math-
ematical model for hospital mortality rates.
DERIVATION OF THE MODEL
The model, though generic to any outcome,
is explicated with respect to hospital mortality.
For each hospital we assume that the rate of
in-hospital mortality (M) can be partitioned
into two components:
M ¼ Uþ V
where U denotes the mortality rate arising from
deaths that could not have been avoided even
under optimal care, and V denotes the mortality
rate arising from deaths due to suboptimal care.
The SMR is deﬁned as the ratio of the actual
number of deaths to the number of deaths
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expected after case mix is taken into account within a
risk-adjustment scheme.
The proportion of the variance in SMRs attributable
to preventable mortality—and the correlation between
these quantities—depends on the contribution of pre-
ventable mortality to overall hospital mortality rates, and
on the performance of the risk-adjustment scheme in
eliminating variation due to differences in case mix.
The critical quantities are:
ξ: the average proportion of deaths that are preventable
(the ‘preventability index’);
cV: the coefﬁcient of variation (deﬁned as SD÷mean) of
the preventable mortality rate across hospitals;
cM: the coefﬁcient of variation of the total in-hospital
mortality rate;
R2: the proportion of the variance in total mortality rates
explained by the risk-adjustment process;
Q: the correlation coefﬁcient between the hospital SMR
and the preventable mortality rate.
The performance of the SMR as a proxy for prevent-
able mortality is governed by the numerical value of Q,
and Q2 can be interpreted as the proportion of the vari-
ation in SMRs attributable to preventable mortality. In
the online appendix an upper bound for Q is derived
under two assumptions. The ﬁrst of these deals with the
possibility that a high rate of natural (unavoidable)
death (U) in a hospital might go hand in hand with a
high rate of preventable death (V). In practice, the pres-
ence of such positive correlation is entirely plausible
since patients at high intrinsic mortality risk are also
those for whom medical error is likely to have the most
catastrophic consequences. As stated, the assumption
(A1) implies that all such correlation between U and V
can be accounted for in terms of case mix factors that
reﬂect that intrinsic risk. The second assumption is con-
cerned with the variation in mortality rates among hospi-
tals with identical case mixes. The simplest version of
the assumption (A2) says that such variation, as mea-
sured by the statistical variance, is the same whatever the
case mix happens to be. As demonstrated in the online
supplementary appendix, this leads unequivocally to the
bound on Q used throughout this paper.
It follows that Q2 will not exceed:
cV
cM
 2 j2
1 R2 ð1Þ
This result enables us to explore the conditions under which
SMRsmay provide a useful indication of preventable mortality.
Assumption A2 may be a sensible ﬁrst approximation,
but it is open to question as an exact description of
reality. Put simply, there is more scope for variability in
rates at case mixes when the mean rate is high than at
case mixes when it is low. For this reason an alternative
assumption (A20) has been entertained, which posits a
proportional relationship between the variance and the
square of the case mix-speciﬁc mean. (This could arise
if case mix differences impact on the relative mortality
risk between hospitals.) Under A20 there may be a
modest inﬂation in the bound for Q, leading to an esti-
mated increase of up to 5% (or 10% for Q2) in the base
case described below (see online supplementary appen-
dix). Such increases are not large enough to disturb the
general conclusions of the paper.
POPULATING THE MODEL
The coefﬁcient of variation of the overall mortality rate
(cM) for 143 Acute Hospital Trusts in England in 2007/8
was 0.19;23 here a base case value for cM of 0.2 has been
assumed.
In the SHMI scheme proposed for the NHS, the pro-
portion of the variance explained by risk adjustment has
been estimated as 81%;18 a value of R2=0.8 has therefore
been assumed.
There appears to be no published study describing
the variation in preventable death rates across hospitals.
However, the variance of the between-hospital compo-
nent of preventable adverse events is given as 0.15 by
Zegers et al.24 We used this ﬁgure, together with infor-
mation in their paper, to compute an approximate
between-hospital SD of 0.42 for the logarithm of the rate
of such events. This roughly corresponds to a coefﬁcient
of variation on the natural scale and informs our base
case choice for cV of 0.4 which, as it happens, is exactly
twice the base case for cM.
Studies of hospital deaths describe the proportion of
deaths that may have been caused by clinical error
(often at low probability),25–27 rather than the propor-
tion of deaths that were preventable. An exception is the
direct estimate (ξ=6%; 95% CI 3.4% to 8.6%) given by
Hayward and Hofer and used here.28
SMRS AS A PROXY FOR RATES OF PREVENTABLE MORTALITY
The expression (1) imposes a severe constraint on the
correlation between hospital SMRs and preventable mor-
tality rates when the parameter values described above
are used. For example, if 6% of deaths are preventable
(as estimated by Hayward and Hofer), and base case
assumptions are made (cM=0.2, cV=0.4, R
2=0.8), it
follows that Q2 cannot exceed:
0:4
0:2
 2 0:062
1 0:8 ¼ 0:072
(or about 0.079 if the alternative assumption A20 is pre-
ferred). Hence it seems that preventable mortality can
account for no more than 8% of the variation in SMRs.
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This leaves very little scope for risk-adjusted mortality to
function as an effective proxy for quality of care.
The point is reinforced if the SMR is treated as a formal
diagnostic test for high rates of preventable mortality.
Suppose that a warning is triggered if the SMR for a hos-
pital places it among the worst 2.5% of all hospitals. This
criterion corresponds to a ‘2-sigma’ action limit for the
SMR. The diagnostic performance of this test depends on
the value of Q2. The positive predictive value (PPV) of
such a warning for identifying a hospital with high prevent-
able mortality will be very low indeed if Q2<0.08, as sug-
gested above. For instance, the PPV for identifying a
hospital with a preventable mortality rate among the worst
2.5% of hospitals would be no more than 0.09 (ie, 9%).
The same applies to the true positive rate (TPR) of the
action limit for correctly detecting high preventable
mortality. In fact the TPR equals the PPV here because
the same fraction (2.5%) has been used to deﬁne the
action limit and to specify the notion of high preventable
mortality. Based on these numbers, at least 10 warnings
out of 11 would be false alarms, and at least 10 out of 11
poorly performing hospitals would escape attention.
At higher levels of the preventability index (ξ) the bound
on Q2 in expression (1) becomes less stringent, and effect-
ive monitoring using the SMR will be correspondingly more
feasible. The effect is illustrated in ﬁgure 1, which shows
how an increase in ξ translates into potential for an
improved PPV (and TPR). Nevertheless, it appears that
worthwhile PPV (or TPR) values can be attained only at
values of ξ well in excess of what is supported by empirical
studies. For example, a PPV of 0.3 would require that more
than 15% of deaths are preventable (ξ>0.15).
DEPARTING FROM THE BASE CASE: THE REALISTIC
SCOPE FOR SMRS
The argument so far has relied on a base case value for cV
(=0.4) grounded in a study of preventable adverse events.
Under this condition, preventable mortality rates vary four-
fold between the 5th and 95th centiles (ﬁgure 2). A lower
value of cV will tighten the constraint (1) on the correl-
ation Q and thus reduce the scope for the SMR to
diagnose poor care. This would be the case if, for
example, the coefﬁcient of variation was the same for pre-
ventable as for overall mortality. For the SMR to function
as an effective proxy for preventable mortality rates, cV
would need to be higher—indeed, much higher—than
the base case value. For example, when ξ=0.06, as in
Hayward and Hofer, a PPV of 0.3 could be achieved only if
cV were increased from 0.4 to 1.0. This would mean that in
a group of 20 randomly chosen hospitals the preventable
death rate is, on average, more than 15 times higher in the
worst hospital compared with the best one (ﬁgure 2). It is
doubtful whether such wide discrepancies among similar
institutions in the same healthcare system are plausible.
Satisfactory diagnostic performance could perhaps be
achieved if both ξ and cV were to exceed their base case
values, but by smaller amounts. For example, case (b) in
ﬁgure 2 envisages a value of ξ (=8.6%) at the upper con-
ﬁdence limit in Hayward and Hofer.28 Then cV need be
no more than 0.7 (case (b)) to achieve the same effect
on the upper bound for Q2 as in case (c). Here prevent-
able mortality rates still would need to differ by an argu-
ably implausible factor of 8.0 between the 95th and 5th
centiles.
DISCUSSION
The results indicate that worthwhile correlations
between case-mix adjusted SMRs and rates of prevent-
able mortality are not attainable unless rates of prevent-
able mortality are either (a) much higher than current
estimates suggest, or (b) implausibly variable between
different hospitals. It can be argued that speciﬁcity is
not crucial to the performance of SMRs, since they are
used as a screen for hospitals requiring further
Figure 1 Diagnostic
performance of the standardised
mortality ratio (2-sigma upper
limit) to detect a hospital among
the worst 2.5% for preventable
deaths. The curve shows the
dependency of the upper bound
for positive predictive value (PPV)
(or true positive rate (TPR)) on
the preventability index under a
risk-adjustment scheme
accounting for 80% of the
variation between hospitals. The
base case relationship cV = 2cM
is assumed.
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investigation, not as a diagnostic trigger for sanction.
However, there is always a trade-off between sensitivity
and speciﬁcity even for screening tests. In the case of
SMRs, high false positives waste resources, stigmatise hos-
pitals, and lead to gaming;29 30 while false negatives
provide false reassurance, thereby deﬂecting attention
away from quality issues across the whole healthcare
system.31 Until risk adjustment can explain much larger
proportions of the variance in mortality it is unsafe to
use high SMRs to identify poor quality of care in any
particular hospital, as has been done recently for some
English hospitals.29 30
Aside from quality of care, possible sources of vari-
ation in hospital SMRs include: differences in discharge
policies leading to variations in underlying mortality
rates; differences in recording practices for primary diag-
noses or comorbidities;20 sampling ﬂuctuations in
observed mortality rates; and failures of the risk adjust-
ment scheme to adequately account for patient differ-
ences. However, a full discussion is beyond the scope of
this paper.
One message from our study is that the diagnostic
value of institution-level outcome data is critically
dependent on the preventability index (ξ) as demon-
strated in ﬁgure 1. In the base case (ξ=6%), PPVs are
very low, although they start to climb steeply once ξ
exceeds about 15%. Most of the relevant literature pro-
vides an estimate of the proportion of deaths for which
a potentially preventable factor was present, rather than
an estimate of the proportion of deaths that were in fact
preventable. For example, Zegers et al32 found an error
that may have been causal in 4% of deaths, while Hogan
et al33 found such a factor that was causative on the
balance of probabilities in 5.2% of deaths. Only
Hayward and Hofer have attempted to measure the crit-
ical quality—the proportion of deaths that were prevent-
able.28 More research into this issue is urgently needed.
The model demonstrates that the predictive value of
SMRs is also highly sensitive to the extent to which pre-
ventability varies across hospitals. An indirect estimate
suggests a coefﬁcient of variation in the rate of prevent-
able deaths in the region of 40% (cV=0.4), consistent
with a fourfold variation in rates across a representative
sample of hospitals. However, there appear to be no
direct estimates of this quantity in the literature. It may
even be that our estimate is too high for a mortality
measure in which eclectic performance across indivi-
duals and departments is aggregated at the hospital
level. In such circumstances variation in the perform-
ance of individual clinical units may be diluted when
these are combined together.
Other things being equal, standardised outcome rates
will discriminate well for speciﬁc conditions in which
preventability rates are high (eg, pressure ulcers, mater-
nal deaths, deaths following elective surgery).23 34 35
Moreover, the variance-dilution effect will be absent
when performance is measured at the level of the indi-
vidual clinical unit. For these reasons standardised mor-
tality rates are likely to be more reliable as a reﬂection
of preventable mortality rates when the unit of compari-
son is relatively discrete (eg, clinical specialities) than
when it is a consolidated measure across separate entities
(eg, hospital-wide outcome rate).
When the preventability index is low, as it is for hos-
pital mortality and many other outcomes in healthcare,
it may be necessary to fall back on direct measurement
of process and outcome by examining individual cases
in detail—for example, by case-note review. Currently,
this method is expensive, though it may become easier
as sophisticated electronic records become widespread.
It is also subject to classiﬁcation errors (eg, judgment of
the preventability of deaths varies by case reviewers). Yet
it may remain the only viable option for measuring pre-
ventable mortality rates unless there are further improve-
ments in risk-adjustment technology.
What this study adds
▸ Hospital standardised mortality ratios (SMRs) are
markers of poor care only to the extent that they
correlate with preventable mortality rates.
▸ A mathematical model populated by empirical estimates
for critical parameters suggests that this correlation is
low.
▸ If preventable deaths make up less than 15% of all
deaths, then SMRs are poor diagnostic tests for
suboptimal care.
Figure 2 Three candidate distributions to describe variation
among hospitals in rates of preventable mortality. The
distributions are scaled to unit median and a log-normal
model is assumed. Under the base case (cV=0.4) the hospital
in the 95th centile would have about four times the
preventable mortality rate of the hospital at the 5th centile.
Under the most dispersed distribution (cV=1.0) the ratio
between the 5th and 95th centiles (ie, 0.25 and 3.93) is more
than 15, an implausibly large range across a random sample
of 20 hospitals.
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